Sort
130,381 grants matching “hiv”
HIV Vaccine Research and Development -Central Nervous System Studies
$1,017,672National Institute Of Allergy And Infectious Diseases · Y01 · FY2014 · AI
Texas Repository for AIDS Neuropathogenesis Research
$1,017,626Benjamin B. Gelman · University Of Texas Med Br Galveston · U01 · FY2011 · MH
Efficacy and cost of HAART DOT in methadone clinics
$1,017,554Yeshiva University · R01 · FY2003 · DA
HIV Research Program in Thailand and Cambodia
$1,017,480Kiat Ruxrungtham · Hiv-Nat, The Thai Red Cross Aids Rch Ctr · U19 · FY2006 · AI
Understanding the Role of the Host Response in HIVSIV Infection
$1,017,478Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Scaling up HPTN 074: a Cluster Randomized Implementation Trial of an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam
$1,017,449Vivian F. Go · Univ Of North Carolina Chapel Hill · R01 · FY2018 · DA
Vaccine Technologies
$1,017,293Jeffrey Ulmer · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2010 · AI
Adjustment Problems and Substance Use in 3 Generations
$1,017,258Deborah M. Capaldi · Oregon Social Learning Center, Inc. · R01 · FY2007 · DA
Clinical Trials Program
$1,017,165Timothy J Wilkin · Weill Medical Coll Of Cornell Univ · U54 · FY2020 · CA
NATURAL HISTORY OF MENOPAUSE IN HIV INFECTED DRUG USERS
$1,017,145Montefiore Medical Center (Bronx, Ny) · R01 · FY2001 · DA
Opiate drug abuse and CNS vulnerability to HIV
$1,017,092Kurt Francis Hauser · Virginia Commonwealth University · P01 · FY2009 · DA
AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans
$1,017,000Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2022 · HG
Reversing effector-to-memory transition at ARTi to impact the HIV reservoir towards ART-free control
$1,016,951Francois J Villinger · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · AI
Therapeutic Disruption of HIV Transcription by HIV-1 Tat Protein-Degrading Molecules
$1,016,887Susana T Valente · University Of Florida · R01 · FY2025 · AI
Faithful Response II: COVID-19 Rapid Test-to-Treat with African American Churches
$1,016,780Jannette Yvonne Berkley-Patton · University Of Missouri Kansas City · U01 · FY2023 · MD
Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV
$1,016,685Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2012 · HL
Byramee Jeejeebhoy Medical College (BJMC), Pune, India: Clinical Trials Unit
$1,016,593Amita Gupta · Johns Hopkins University · UM1 · FY2012 · AI
Biomarker Signatures of TB Infection in Young Children With and Without HIV
$1,016,533Padmini Salgame · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Clonal Dynamics of HIV/SIV-specific T cells
$1,016,532Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
HIV Database for HIV - AIDS Therapeutics and Microbicides
$1,016,287Margaret Rush · Gryphon Scientific, Llc · N01 · FY2015 · AI
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$1,015,999Gail Geller · Johns Hopkins University · RM1 · FY2016 · HG
MANAGEMENT OF INFORMATION RESOURCES ON THERAPEUTIC AGENTS FOR HIV AND OPPORTUNIS
$1,015,796Margaret Andrews Rush · Gryphon Scientific, Llc · N01 · FY2010 · AI
Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM)
$1,015,767C. Hendricks Brown · Northwestern University At Chicago · P30 · FY2019 · DA
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORK
$1,015,636University Of Miami School Of Medicine · U10 · FY2003 · DA
TICIPS: HIV/AIDS, Secondary Infections and Immune Modulation
$1,015,567William Robert Folk · University Of Missouri-Columbia · U19 · FY2007 · AT